|
| |
| | | 68548 | | 27.10.2022 | | UCB-Pharma SA | | | | | | | 26.10.2027 | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Bimzelx 160 mg | solution injectable en seringue préremplie | solution injectable en seringue préremplie (Bimekizumabum 160 mg/ml) | L04AC21 | CI | | 02 | Bimzelx 320 mg | solution injectable en seringue préremplie | solution injectable en seringue préremplie (Bimekizumabum 320mg / 2ml) | L04AC21 | CI |
|
|
|
